The device was not returned for analysis as it was implanted in the patient.Neurological deterioration is a known inherent risk of endovascular procedure and are documented in our device¿s instruction for use (ifu).Based on the reported information, there is no evidence suggesting that the device was defective, but rather a post procedure and patient condition related event.If information is provided in the future, a supplemental report will be issued.
|
Medtronic received report that post the uneventful pipeline embolization procedure of an unruptured 24mm aneurysm, the patient was reported to have neurological deterioration that consisted of ¿mass effect deterioration¿ (4th day post tx.), ocular movement disorder.Approximately, one month later the patient was reported to have mass effect deterioration, headache, vomiting, nausea and ocular movement disorder.2 years post the initial treatment the symptoms of optic nerve were none.The mass effect was unchanged.Mrs two years after the procedure: 2 the aneurysm was in the left internal carotid artery - cavernous / unruptured saccular aneurysm in the cavernous sinus (maximum diameter: 23.9 mm, neck width: 16.2 mm).Past history: smoking in the past, mass effect.
|